Abstract

Background: As it was mentioned, the risk of adverse effects and complications is more than what is expected. Hence, the use of epidural analgesia (EA) was decreased in the management of post-operative pain. Hence, there is a need for another pharmacological agent that is more effective. Manly studies reported that buprenorphine transdermal and sublingual both have significant pain relief scores. Aims and Objectives: The present study was undertaken to compare the pain relief scores of epidural midazolam and buprenorphine for post-operative patients. Materials and Methods: A total of 60 male and female participants, within the age group with the American Society of Anesthesiologists grades I and II were recruited. After recruiting, they were randomly divided into two groups. Soon after the surgery, the pain scores were recorded using the Visual Analog Scale. Soon after recording the pain scores, the corresponding drugs were administered to the participants. Epidural midazolam 30 g/kg and buprenorphine 0.15 mg diluted in normal saline were administered to the corresponding groups for 24 h. Results: There is no significant difference in the demographic data of the participants in both groups. There was no significant difference observed between the two groups. Both are equally effective. Nausea and vomiting are the mild side effects observed in the majority of the patients in both groups. Conclusion: In the present study, we have observed similar actions by both drugs in the management of post-operative pain. The study not only adds to the literature about the effectiveness of these drugs but also explains the mild side effects. Hence, the study recommends the use of both these drugs in the management of post-operative pain so that patient satisfaction can be improved and the patient stay at the hospital can be minimized. Further, detailed and multi-center studies are recommended to generalize the results.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.